Autoantibodies to autonomic neurotransmitter receptors-A unique pathway of neuro-immune interactions

Circulating autoantibodies directed against receptors of various autonomic neurotransmitters, including the muscarinic and nicotinic ganglionic acetylcholine-receptor and the beta-1-adrenergic receptor have been detected in patients with various autoimmune diseases. These antibodies have been hypoth...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerző: Kovács László
Dokumentumtípus: Cikk
Megjelent: 2012
Sorozat:ADVANCES IN NEUROIMMUNE BIOLOGY 3 No. 2
doi:10.3233/NIB-2012-012045

mtmt:2504823
Online Access:http://publicatio.bibl.u-szeged.hu/18535
LEADER 01751nab a2200205 i 4500
001 publ18535
005 20200409144657.0
008 200409s2012 hu o 0|| zxx d
022 |a 1878-948X 
024 7 |a 10.3233/NIB-2012-012045  |2 doi 
024 7 |a 2504823  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Kovács László 
245 1 0 |a Autoantibodies to autonomic neurotransmitter receptors-A unique pathway of neuro-immune interactions  |h [elektronikus dokumentum] /  |c  Kovács László 
260 |c 2012 
300 |a 209-215 
490 0 |a ADVANCES IN NEUROIMMUNE BIOLOGY  |v 3 No. 2 
520 3 |a Circulating autoantibodies directed against receptors of various autonomic neurotransmitters, including the muscarinic and nicotinic ganglionic acetylcholine-receptor and the beta-1-adrenergic receptor have been detected in patients with various autoimmune diseases. These antibodies have been hypothesised to have a direct influence on the function of the target organ, including exocrine glandular function, smooth muscle or myocardium contractility. The potential immune-mediated function-modifying interaction between the immune and the autonomic nervous system has inspired interesting experiments. These studies have explored unique pathways whereby autoantibodies may alter the cellular and tissue homeostasis leading to organ damage. The present review summarises these results, with particular focus on anti-muscarinic receptor antibodies in Sjögren's syndrome, and highlights the difficulties in the detection of anti-neurotransmitter receptor antibodies. ©2012-IOS Press and the authors. All rights reserved. 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/18535/1/KovacsAdvNeuroimmBiol2012.pdf  |z Dokumentum-elérés